Sort
39,280 grants matching “leukemia”
CELLULAR RETINOIC ACID BINDING PROTEIN--FUNCTIONAL STUDI
$325,071Weill Medical College Of Cornell Univ · R01 · FY2000 · CA
Targeting the p62 signalosome in leukemia.
$325,064Jing Fang · University Of South Carolina At Columbia · R01 · FY2019 · CA
TR2 nuclear receptor in vitamin A signaling
$325,058Li-Na Wei · University Of Minnesota · R01 · FY2012 · DK
TR2 nuclear receptor in vitamin A signaling
$325,058Li-Na Wei · University Of Minnesota · R01 · FY2014 · DK
TR2 nuclear receptor in vitamin A signaling
$325,058Li-Na Wei · University Of Minnesota · R01 · FY2015 · DK
Targeting Hsp60 to Inhibit CREB-mediated Gene Transcription
$325,056Xiangshu Xiao · Oregon Health & Science University · R01 · FY2017 · GM
A Genetic Screen for HCC Genes
$325,038David Andrew Largaespada · University Of Minnesota · R01 · FY2010 · CA
ANTITUMOR AGENTS FROM BLUE-GREEN ALGAE
$325,000University Of Hawaii At Manoa · R01 · FY2001 · CA
Involvement of Survivin in the Development of PML
$325,000Luis Del Valle · Temple Univ Of The Commonwealth · R01 · FY2007 · NS
Lyn Kinase-Mediated Regulation of Allergic Inflammation
$325,000Johns Hopkins University · R56 · FY2005 · AI
Molecular mechanism of chromatin targeting by BRPF1
$324,995Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2017 · GM
Molecular mechanism of chromatin targeting by BRPF1
$324,995Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2018 · GM
Molecular mechanism of chromatin targeting by BRPF1
$324,995Tatiana G Kutateladze · University Of Colorado Denver · R01 · FY2016 · GM
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity
$324,994Xuanmao Jiao · Lightseed, Inc. · R43 · FY2022 · HL
Regulation of Mast Cell Function by Inhibitory Molecules
$324,993Vanessa L Ott · University Of Wisconsin-Madison · R01 · FY2006 · AI
MODULATING GVH/GVL POST-BMT USING TK EXPRESSING T CELLS
$324,990Medical College Of Wisconsin · R01 · FY2000 · HL
Cellular and Molecular mechanisms of ATRA inhibition of osteoblast-induced MDS development
$324,966Stavroula Kousteni · Columbia University Health Sciences · R01 · FY2024 · AR
Processing and consequences of DNA-protein crosslinks in E. coli
$324,903Kenneth N Kreuzer · Duke University · R01 · FY2012 · GM
Processing and consequences of DNA-protein crosslinks in E. coli
$324,903Kenneth N Kreuzer · Duke University · R01 · FY2011 · GM
Clinical Significance of MHC Haplotypes in HCT
$324,901Effie W Petersdorf · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
$324,900Anthony G Letai · Dana-Farber Cancer Inst · R01 · FY2007 · CA
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
$324,900Anthony G Letai · Dana-Farber Cancer Inst · R01 · FY2009 · CA
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
$324,900Anthony G Letai · Dana-Farber Cancer Inst · R01 · FY2010 · CA
Differentiating Agents in Hematologic Malignancies
$324,900Dana-Farber Cancer Institute · R01 · FY2005 · CA
Differentiating Agents in Hematologic Malignancies
$324,900Dana-Farber Cancer Institute · R01 · FY2004 · CA